Health & Biotech
Health Check: Actinogen powers ahead with key Alzheimer’s disease trial
ASX health stocks riding China’s two-way silk road for wellness at import expo
BlinkLab joins ‘landmark’ Monash University autism/ADHD project
Health Check: Could the White House be about to welcome LSD and magic mushrooms into the Oval Office?
Five ASX healthcare companies poised for game-changing catalysts
Biocurious: No sweat as Botanix tackles the world’s third-biggest skin disorder
LTR Pharma joins with leading men’s health group to launch telehealth platform
Health Check: It’s a small world after all for global microcap index additions LTR Pharma and EZZ Life Science
Institutional investors power HeraMED’s maternity care revolution with $1m
Dr Boreham’s Crucible: Transforming the cardiac ablation market takes ticker… and time
Dr Anthony Filippis to helm Neurotech as it advances its NTI164 strategy in 2025
NUZ inks positive opinion on orphan product designation for NUZ-001 in Europe
Recce green lit to begin dosing in registrational Phase 3 trial for diabetic foot infections
Scott Power: ACCC’s approval of Sigma, Chemist Warehouse union turned heads this week
Health Check: Neuren’s ‘Willy Wonka’ voucher shows how a piece of paper can be worth US$50m
Health Check: Prestigious publication supports Alterity’s ‘iron overload in brain’ thesis
Spark Plus sees 225pc upside in biotech player Neurizon
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
